These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 17553085)
1. Methyl 3-[3',4'-(methylenedioxy)phenyl]-2-methyl glycidate: an ecstasy precursor seized in Sydney, Australia. Collins M; Heagney A; Cordaro F; Odgers D; Tarrant G; Stewart S J Forensic Sci; 2007 Jul; 52(4):898-903. PubMed ID: 17553085 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of N-tert-butoxycarbonyl-MDMA: a new MDMA precursor. Collins M; Donnelly C; Cameron S; Tahtouh M; Salouros H Drug Test Anal; 2017 Mar; 9(3):399-404. PubMed ID: 27574107 [TBL] [Abstract][Full Text] [Related]
3. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong. Cheng WC; Poon NL; Chan MF J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267 [TBL] [Abstract][Full Text] [Related]
4. N-cyanomethyl-N-methyl-1-(3',4'-methylenedioxyphenyl)-2-propylamine: an MDMA manufacturing by-product. Salouros H; Collins M; Tarrant G; George AV J Forensic Sci; 2008 Sep; 53(5):1083-91. PubMed ID: 18637869 [TBL] [Abstract][Full Text] [Related]
5. Identification and quantitation of 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) in human urine by 1H NMR spectroscopy. Application to five cases of intoxication. Liu J; Decatur J; Proni G; Champeil E Forensic Sci Int; 2010 Jan; 194(1-3):103-7. PubMed ID: 19926414 [TBL] [Abstract][Full Text] [Related]
6. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity]. Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497 [TBL] [Abstract][Full Text] [Related]
7. Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method. Visser HA; Visser-van Leeuwen M; Huizer H Bull Narc; 2005; 57(1-2):167-82. PubMed ID: 21338020 [TBL] [Abstract][Full Text] [Related]
8. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe. Liu C; Jia W; Qian Z; Li T; Hua Z Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255 [TBL] [Abstract][Full Text] [Related]
9. Solid-phase extraction for profiling of ecstasy tablets. Rashed AM; Anderson RA; King LA J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963 [TBL] [Abstract][Full Text] [Related]
10. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy). Carter JF; Titterton aE; Murray M; Sleeman R Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919 [TBL] [Abstract][Full Text] [Related]
11. Quantum-chemical, NMR and X-ray diffraction studies on (+/-)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane. Zapata-Torres G; Cassels BK; Parra-Mouchet J; Mascarenhas YP; Ellena J; De Araujo AS J Mol Graph Model; 2008 Jun; 26(8):1296-305. PubMed ID: 18280190 [TBL] [Abstract][Full Text] [Related]
12. The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities. Plummer CM; Breadon TW; Pearson JR; Jones OAH Sci Justice; 2016 May; 56(3):223-230. PubMed ID: 27162021 [TBL] [Abstract][Full Text] [Related]
13. A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis. Renton RJ; Cowie JS; Oon MC Forensic Sci Int; 1993 Aug; 60(3):189-202. PubMed ID: 7901132 [TBL] [Abstract][Full Text] [Related]
14. Establishing the synthetic origin of amphetamines by 2H NMR spectroscopy. Armellin S; Brenna E; Fronza G; Fuganti C; Pinciroli M; Serra S Analyst; 2004 Feb; 129(2):130-3. PubMed ID: 14752555 [TBL] [Abstract][Full Text] [Related]
15. The variability of ecstasy tablets composition in Brazil. Togni LR; Lanaro R; Resende RR; Costa JL J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149 [TBL] [Abstract][Full Text] [Related]
16. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)]. Verweij AM Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250 [TBL] [Abstract][Full Text] [Related]
17. Supported liquid-liquid extraction of the active ingredient (3,4-methylenedioxymethylamphetamine) from ecstasy tablets for isotopic analysis. de Korompay A; Hill JC; Carter JF; NicDaeid N; Sleeman R J Chromatogr A; 2008 Jan; 1178(1-2):1-8. PubMed ID: 18070626 [TBL] [Abstract][Full Text] [Related]
18. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair. Wu YH; Lin KL; Chen SC; Chang YZ J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989 [TBL] [Abstract][Full Text] [Related]
19. Impurity profiling/comparative analyses of samples of 1-phenyl-2-propanone. Krawczyk W; Kunda T; Perkowska I; Dudek D Bull Narc; 2005; 57(1-2):33-62. PubMed ID: 21338015 [TBL] [Abstract][Full Text] [Related]
20. Availability of target odor compounds from seized ecstasy tablets for canine detection. Macias MS; Furton KG J Forensic Sci; 2011 Nov; 56(6):1594-600. PubMed ID: 21827456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]